Showing Publication (ASENSI 2002)

Asensi M., Medina I., Ortega A., Carretero J., Bano M.C., Obrador E., Estrela J.M. (2002) Inhibition of cancer growth by resveratrol is related to its low bioavailability. Free Radic Biol Med 33:387-98 PubMed (15736313)

Abbreviation: ASENSI 2002

Pubmed ID: 15736313

Created on 2015-04-13 at 05:45PM EDT

Updated on 2015-04-13 at 12:25AM EDT

Metabolism

This publication was used in 3 intervention studies.

Source	Metabolite	Biofluid	Organism
trans-Resveratrol	Trans-Resveratrol	plasma	rabbit	Pharmacokinetics
trans-Resveratrol	Trans-Resveratrol	plasma	rat	Pharmacokinetics
trans-Resveratrol	Trans-Resveratrol	plasma	mouse	Pharmacokinetics